Serum Resistin Level Following Non-surgical Periodontal Therapy in Diabetic Patients With Chronic Periodontitis
NCT ID: NCT04473209
Last Updated: 2020-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-09-01
2020-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Hs-CRP in Periodontitis Patients With or Without Diabetes
NCT03908606
Effect of Non-surgical Periodontal Treatment on HbA1c in Type 2 Diabetic Patients
NCT02652026
Evaluation of Non - Surgical Periodontal Therapy in Diabetic Patients.
NCT03764410
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
NCT02174146
Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy
NCT03343366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: Forty individuals were recruited in this study and were divided into three groups, diabetic group consisted of 15 diabetic patients (type 2 diabetes mellitus) with moderate to severe chronic periodontitis, non-diabetic group consisted of 15 non-diabetic patients with moderate to severe chronic periodontitis and healthy group consisted of 10 non-diabetic individuals with healthy periodontium. Non-surgical periodontal therapy with supra and subgingival debridement was performed for the diabetic and non-diabetic groups. Pocket depth, clinical attachment level, plaque index, gingival index, serum Resistin and high sensitivity C-Reactive Protein assay were recorded for both groups before and after treatment, while HbA1c was recorded for the diabetic group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
diabetic group
diabetic patients with chronic periodontitis
non-surgical periodontal therapy
supra and subgingival debridement
non-diabetic group
non diabetic patients with chronic periodontitis
non-surgical periodontal therapy
supra and subgingival debridement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-surgical periodontal therapy
supra and subgingival debridement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of a minimum of 15 natural teeth
* Presence of at least four teeth with one or more sites with probing pocket depth (PPD) ≥5mm and clinical attachment level (CAL) ≥4mm
* agreement to participate in the study and sign a written informed consent
Exclusion Criteria
* A history of antibiotics therapy and anti-inflammatory drugs within the previous 6 months
* Pregnancy or use of contraceptives or any medication related to diabetes
* former or current smokers ˂ 5 years.
40 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weam Ahmed Elbattawy
Dr. Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
version 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.